Shijiazhuang Yuncang Water Technology Corporation Limited

Indima ye-TCCA kuthintelo lwe-COVID-19

Indima yeTriclosankuthintelo nakunyango lwe-COVID-19 iye yaba sisihloko esibaluleke ngakumbi njengoko ilizwe liqhubeka ukulwa le ntsholongwane ibulalayo.I-Trichloroisocyanuric acid (I-TCCA) luhlobo oluthile lwesibulali ntsholongwane esifumana ukuthandwa ngenxa yokusebenza kwayo okungqiniweyo ngokuchasene neentlobo ngeentlobo zeentsholongwane kunye neebhaktheriya, kubandakanywa nezo zinxulunyaniswa nosulelo lwenoveli lwe-coronavirus.

I-Trichloroisocyanuric acid isebenza ngokwaphula iiproteni ezithile kumphezulu weentsholongwane ezithile okanye iibhaktheriya, ngaloo ndlela inceda ekunciphiseni.Inkqubo ibizwa ngokuba yi-chlorination kwaye isetyenziswe iminyaka emininzi njengendlela yokucocwa kwamanzi kunye neenjongo zococeko kwizibhedlele, amachibi okubhukuda, i-spas, iinkqubo zamanzi okusela, kunye nokunye.

Ngokumalunga nokuthintela usulelo lwenoveli yekoronavirus, i-TCCA inokongezwa ngokuthe ngqo kumadama okuqubha kugxininiso lwe-0.2-1 ppm (iinxalenye ngesigidi) kangangexesha elifutshane ukunceda ukunciphisa umthamo wentsholongwane egazini kwimiphezulu efana neetafile okanye izitulo abantu. touch yenza njengeIsibulali-zintsholongwane.Iyenzeka rhoqo kubomi bemihla ngemihla.Ukongezelela, ezinye izifundo zibonise ukuba xa i-nebulised (i-inhaled), i-TCCA inokunceda ukunciphisa izinga lokudluliselwa emoyeni okuhambelana neendawo zoluntu ngexesha lomkhuhlane.

Njengoko siqhubeka sikhangela iindlela ezingcono zokujongana ne-Covid 19 kwihlabathi jikelele, ukuqonda ukuba i-trichloroisocyanuric acid inokudlala njani indima kwizicwangciso zokuthintela ezifana ne-chlorination yamadama okuqubha okanye iinzame zokuhlanjululwa kwiisethingi zokhathalelo lwezempilo ziya kuba yiyo yonke imiba ebalulekileyo ukuya phambili.Ngokunikwa into esele siyayazi malunga neepropathi zayo ze-antiviral, ukusetyenziswa kwayo ngokukhuselekileyo nolunye unyango kuhlala kulithemba elinika umdla.

  • Ngaphambili:
  • Okulandelayo:

  • Ixesha lokuposa: Feb-27-2023